It is recommended that patients with any of the following undergo genetic risk evaluation: (1) adrenocortical carcinoma (ACC); (2) paraganglioma/pheochromocytoma; (3) gastrinoma (duodenal/pancreatic or type 2 gastric neuroendocrine tumor [NET]); (4) multifocal pancreatic NETs; (5) parathyroid ade...
NCCN GUIDELINES ® 2022 FOR PATIENTS Neuroendocrine Tumors Presented with support from: Available online at NCCN.org/patients Ü Neuroendocrine Tumors Its easy to get lost in the cancer world Let NCCN Guidelines for Patients® be your guide 9 Step-by-step guides to the cancer care opti...
GuidelinesVersion1.2022NeuroendocrineandAdrenalTumorsdexforNeuroendocrineandAdrenalTumorsfromVersionincludeNeuroendocrineTumorsofthePancreas(Well-DifferentiatedGrade1/2)PanNET-2A•Footnoteremoved:SeePrinciplesofSystemicAnti-TumorTherapy(NE-F).(AlsopagesPanNET-4andPanNET-5)•Newfootnotenadded:Forsymptomand/ortumor...
Principles of Liver Directed Therapy for Neuroendocrine Tumor Metastases (NE-G) Principles of Hormone Control (NE-H) Staging (ST-1) Clinical Trials: NCCN believes that the best management for any patient with cancer is in a clinical trial. ...
(typical carcinoids). SCLC and LCNEC are poorly differentiated tumors that often have a poor prognosis, whereas typical carcinoid is a well-differentiated neuroendocrine tumor that usually has a good prognosis. Atypical carcinoid is a moderately differentiated neuroendocrine cancer and, as such, carries...
neuroendocrine carcinoma) from low-grade (typical carcinoid), intermediate-grade (atypical carcinoid), or large-cell neuroendocrine carcinoma (LCNEC) (which is also a high-grade neuroendocrine carcinoma) (see the NCCN Guidelines for Lung Neuroendocrine Tumors and Lung Neuroendocrine Tumors in this ...
7 Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009...
UpdatesinVersion1.2024oftheNCCNGuidelinesforNon-SmallCellLungCancerfromVersion5.2023include: NSCL-H8of8 PlasmaCell-Free/CirculatingTumorDNA(ctDNA)Testing Sub-bullet2added:ctDNAisnotroutinelyrecommendedinsettingsotherthanadvanced/metastaticdisease.ForstagesI–III,tissue-basedtestingis preferred.Metastaticdiseaseconi...
NCCN Guidelines for Patients Breast Cancer NCCN Guidelines with NCCN Evidence Blocks™ –About NCCN Evidence Blocks™ NCCN Guidelines Noninvasive Invasive Phyllodes Tumor Paget's Disease Breast Cancer During Pregnancy Inflammatory Breast Cancer NCCN Framework for Resource Stratification of NCCN Guidelines...
NCCN Guidelines Version 1.2014 Lung Neuroendocrine Tumors CLINICAL STAGE c PRIMARY TREATMENT NCCN Guidelines Index SCLC Table of Contents Discussion ADJUVANT TREATMENT Low grade (typical) Surgery: d Lobectomy or other anatomic resection e + mediastinal lymph node dissection or sampling Stage I, II, III...